Immunosuppressive agents and infectious risk in transplantation: managing the “net state of immunosuppression”

MB Roberts, JA Fishman - Clinical Infectious Diseases, 2021 - academic.oup.com
Successful solid organ transplantation reflects meticulous attention to the details of
immunosuppression, balancing risks for graft rejection against risks for infection. The “net …

Immunosuppressive drugs for kidney transplantation

PF Halloran - New England Journal of Medicine, 2004 - Mass Medical Soc
Suppression of allograft rejection is central to successful organ transplantation; thus,
immunosuppressive agents are crucial for successful allograft function. Immunosuppressive …

[HTML][HTML] Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody

C Wiebe, IW Gibson, TD Blydt-Hansen… - American Journal of …, 2015 - Elsevier
Understanding rates and determinants of clinical pathologic progression for recipients with
de novo donor-specific antibody (dnDSA), especially subclinical dnDSA, may identify …

[HTML][HTML] Diagnosis and management of antibody-mediated rejection: current status and novel approaches

A Djamali, DB Kaufman, TM Ellis, W Zhong… - American Journal of …, 2014 - Elsevier
Advances in multimodal immunotherapy have significantly reduced acute rejection rates and
substantially improved 1-year graft survival following renal transplantation. However, long …

Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy

AL Taylor, CJE Watson, JA Bradley - Critical reviews in oncology …, 2005 - Elsevier
Effective immunosuppression is an essential pre-requisite for successful organ
transplantation and improvements in outcome after transplantation have to a large extent …

Steroid avoidance or withdrawal for kidney transplant recipients

MC Haller, A Royuela, EV Nagler… - Cochrane Database …, 2016 - cochranelibrary.com
Background Steroid‐sparing strategies have been attempted in recent decades to avoid
morbidity from long‐term steroid intake among kidney transplant recipients. Previous …

Antibody-mediated organ-allograft rejection

RB Colvin, RN Smith - Nature Reviews Immunology, 2005 - nature.com
Recent studies show that alloantibodies mediate a substantial proportion of graft-rejection
episodes, contributing to both early and late graft loss. Rejection that is caused by antibody …

Transplantation 50 years later—progress, challenges, and promises

MH Sayegh, CB Carpenter - New England Journal of Medicine, 2004 - Mass Medical Soc
A half-century has elapsed since the first transplantation, and this procedure is now
accepted as the treatment of choice for end-stage organ failure. This article reviews the …

Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation

JL Jones, SAJ Thompson, P Loh… - Proceedings of the …, 2013 - National Acad Sciences
The association between lymphopenia and autoimmunity is recognized, but the underlying
mechanisms are poorly understood and have not been studied systematically in humans …

[HTML][HTML] Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion

JP Pearl, J Parris, DA Hale, SC Hoffmann… - American journal of …, 2005 - Elsevier
T-cell depletion facilitates reduced immunosuppression following organ transplantation and
has been suggested to be pro-tolerant. However, the characteristics of post-depletional T …